SCHEMBL6190822

SCHEMBL6190822

Cc1nc2c(s1)Cc1cc(C)c(C)cc1-2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 12/20 0.49
FBP1 P09467 3/20 0.38
CHEK1 O14757 1/20 0.37
DAPK3 O43293 1/20 0.37
LTK P29376 1/20 0.37
MAPK8 P45983 1/20 0.37
CSNK1A1 P48729 1/20 0.37
CDK8 P49336 1/20 0.37
LIMK1 P53667 1/20 0.37
CDK5 Q00535 1/20 0.37
DYRK1A Q13627 1/20 0.37
LRRK2 Q5S007 1/20 0.37
CLK4 Q9HAZ1 1/20 0.37
DYRK1B Q9Y463 1/20 0.37
GAA P10253 1/20 0.36
NPC1 O15118 1/20 0.35
TDP2 O95551 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL7903347 0.98 ADORA1 (0.48) ADORA1FBP1CHEK1DAPK3LTK
SCHEMBL6191799 0.89 ADORA1 (0.42) ADORA1FBP1NPC1TDP2ALDH1A1
Iodide SCHEMBL3987555 0.81 ADORA1 (0.73) ADORA1FBP1CHEK1DAPK3LTK
SCHEMBL6191569 0.77 ADORA1 (0.50) ADORA1FBP1CHEK1DAPK3LTK
Hydrochloric Acid SCHEMBL7895436 0.76 ADORA1 (0.49) ADORA1FBP1CHEK1DAPK3LTK
SCHEMBL12798139 0.75 CHEK1 (0.65) ADORA1FBP1CHEK1DAPK3LTK
SCHEMBL17339841 0.72 CHEK1 (0.47) ADORA1FBP1CHEK1DAPK3LTK
SCHEMBL13827812 0.71 FBP1 (0.36) ADORA1FBP1GAANPC1ALDH1A1
SCHEMBL10356404 0.68 KDM4E (0.33) ADORA1GAANPC1ALDH1A1MAPT
SCHEMBL10356745 0.67 RAB9A (0.46) ADORA1GAANPC1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1183247-B1 POLYCYCLIC THIAZOLE SYSTEMS AND THEIR UTILIZATION AS ANORECTICS AVENTIS PHARMA GMBH (DE) 2005-05-25 EP disclosed
EP-1156805-B1 USE OF POLYCYCLIC THIAZOLE SYSTEMS FOR MANUFACTURING MEDICAMENTS FOR PREVENTING OR TREATING OBESITY AVENTIS PHARMA GMBH (DE) 2004-08-11 EP disclosed
EP-1183247-A1 POLYCYCLIC THIAZOLE SYSTEMS AND THEIR UTILIZATION AS ANORECTICS Aventis Pharma Deutschland GmbH (DE) 2002-03-06 EP disclosed
EP-1156805-A2 USE OF POLYCYCLIC THIAZOLE SYSTEMS FOR PRODUCING MEDICAMENTS FOR PREVENTING OR TREATING OBESITY Aventis Pharma Deutschland GmbH (DE) 2001-11-28 EP disclosed
WO-2000051997-A1 POLYCYCLIC THIAZOLE SYSTEMS AND THEIR UTILIZATION AS ANORECTICS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-09-08 WO disclosed
WO-2000051579-A2 USE OF POLYCYCLIC THIAZOLE SYSTEMS FOR PRODUCING MEDICAMENTS FOR PREVENTING OR TREATING OBESITY AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-09-08 WO disclosed